Pharmaceutical Industry Growth Prospects Surveyed by Kable in In-demand Report Published at MarketPublishers.com26 Feb 2014 • by Natalie Aster
LONDON – Far over half of the world pharmaceutical industry executives have the positive outlook for the growth prospects of companies as well as for those of the industry as a whole in H1 2014. The degree of optimism regarding the company and industry perspectives has recently increased, driven primarily by the constantly improving economic conditions worldwide, rising investments in emerging markets, and the launch of novel products in the marketplace.
The number of the major concerns for the overall pharmaceutical industry executives include, among others, intensifying competition from the new market entrants, the Eurozone’s performance, new government initiatives and legislation, and the state of the global economy. The suppliers’ feedstock costs are predicted to register the average growth of around 4.1% during H1 2014 with the rates witnessed in the APAC region. The pharmaceutical market participants are expected to increase investments in new product development and marketing areas during Q1-Q2 2014.
In-demand survey report “Pharmaceutical Business Confidence Report Q1 2014” prepared by Kable contains a thorough analysis of the important aspects of the world pharmaceutical industry.
This topical report uncovers the opinions of the top pharmaceutical industry executives about the worldwide economy, suppliers’ prices, customer confidence, major business concerns, and also presents discussions of the promising investment areas in Q1 2014. The research study offers a close look at the regional markets scenario, outlines the industry future growth prospects, characterizes the sales performance, covers the staff hiring issues and pinpoints the top market opportunities. The report not only grants access to the opinions and strategies of the leading pharmaceutical industry executives, but also scrutinizes their actions surrounding opportunities, threats, business priorities and future investment pockets through the next 6 months. Furthermore, the survey findings are compared with the results of Q4 2013 wherever applicable.
Title: Pharmaceutical Business Confidence Report Q1 2014
Published: January, 2014
Price: US$ 1,950.00
Other Studies by Kable Include:
- IT Business Confidence Report Q1 2014
- Top ICT spenders in the Italian Retail Banking Industry - Estimated ICT budget breakdowns in 2013
- Top ICT spenders in the Italian Media Industry - Estimated ICT budget breakdowns in 2013
More insightful research reports by the publisher can be found at Kable page.